Welcome to Medications.com

Pacgen Reports Third Quarter Financial Results - Web Services Journal

This study is a randomized, examiner-blinded, parallel design trial comparing three different doses of PAC-113 to Nystatin. Nystatin is a widely used, ...

http://www.sys-con.com/read/50962... | Posted: Fri Feb 29 17:18:16 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea